Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins - 14/06/13

Jaehwan Kim, MD, PhD ^{a, c}, Kwesi Teye, PhD ^{e, f}, Hiroshi Koga, MD, PhD ^{e, f}, Sue-Ching Yeoh, BDS, MDSc, FRACDS ^b, Denis Wakefield, DSc, MD, MBBS, FRACP, FRCPA, FFSc ^d, Takashi Hashimoto, MD ^{e, f}, Dedee F. Murrell, MA, BMBCh, FAAD, MD, FACD ^{a, c, ⁎}

^a Department of Dermatology, St George Hospital, Sydney, Australia 

^b Oral Medicine and Oral Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia 

^c Faculty of Medicine, University of New South Wales, Sydney, Australia 

^d School of Medical Sciences, University of New South Wales, Sydney, Australia 

^e Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan 

^f Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan 

^∗Correspondence to: Dedee F. Murrell, MA, BMBCh, FAAD, MD, FACD, Department of Dermatology, St George Hospital, Gray Street, Kogarah, Sydney, New South Wales 2217, Australia